☰

Jean-matthieu Prot - Publications

Affiliations: 
Compiègne 
Tree Info Similar researchers PubMed Report error

13/17 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Stancescu M, Molnar P, McAleer CW, McLamb W, Long CJ, Oleaga C, Prot JM, Hickman JJ. A phenotypic in vitro model for the main determinants of human whole heart function. Biomaterials. 60: 20-30. PMID 25978005 DOI: 10.1016/J.Biomaterials.2015.04.035  0.37
2015 Esch MB, Prot JM, Wang YI, Miller P, Llamas-Vidales JR, Naughton BA, Applegate DR, Shuler ML. Multi-cellular 3D human primary liver cell culture elevates metabolic activity under fluidic flow. Lab On a Chip. 15: 2269-77. PMID 25857666 DOI: 10.1039/C5Lc00237K  0.38
2014 Prot JM, Maciel L, Bricks T, Merlier F, Cotton J, Paullier P, Bois FY, Leclerc E. First pass intestinal and liver metabolism of paracetamol in a microfluidic platform coupled with a mathematical modeling as a means of evaluating ADME processes in humans. Biotechnology and Bioengineering. 111: 2027-40. PMID 24954399 DOI: 10.1002/Bit.25232  0.68
2013 Smith AS, Long CJ, Berry BJ, McAleer C, Stancescu M, Molnar P, Miller PG, Esch MB, Prot JM, Hickman JJ, Shuler ML. Microphysiological systems and low-cost microfluidic platform with analytics. Stem Cell Research & Therapy. 4: S9. PMID 24565109 DOI: 10.1186/Scrt370  0.404
2013 Baudoin R, Prot JM, Nicolas G, Brocheton J, Brochot C, Legallais C, Benech H, Leclerc E. Evaluation of seven drug metabolisms and clearances by cryopreserved human primary hepatocytes cultivated in microfluidic biochips. Xenobiotica; the Fate of Foreign Compounds in Biological Systems. 43: 140-52. PMID 22830982 DOI: 10.3109/00498254.2012.706725  0.698
2012 Ouattara DA, Prot JM, Bunescu A, Dumas ME, Elena-Herrmann B, Leclerc E, Brochot C. Metabolomics-on-a-chip and metabolic flux analysis for label-free modeling of the internal metabolism of HepG2/C3A cells. Molecular Biosystems. 8: 1908-20. PMID 22618574 DOI: 10.1039/C2Mb25049G  0.66
2012 Cheng S, Prot JM, Leclerc E, Bois FY. Zonation related function and ubiquitination regulation in human hepatocellular carcinoma cells in dynamic vs. static culture conditions. Bmc Genomics. 13: 54. PMID 22296956 DOI: 10.1186/1471-2164-13-54  0.59
2012 Shintu L, Baudoin R, Navratil V, Prot JM, Pontoizeau C, Defernez M, Blaise BJ, Domange C, Péry AR, Toulhoat P, Legallais C, Brochot C, Leclerc E, Dumas ME. Metabolomics-on-a-chip and predictive systems toxicology in microfluidic bioartificial organs. Analytical Chemistry. 84: 1840-8. PMID 22242722 DOI: 10.1021/Ac2011075  0.709
2012 Prot JM, Bunescu A, Elena-Herrmann B, Aninat C, Snouber LC, Griscom L, Razan F, Bois FY, Legallais C, Brochot C, Corlu A, Dumas ME, Leclerc E. Predictive toxicology using systemic biology and liver microfluidic "on chip" approaches: application to acetaminophen injury. Toxicology and Applied Pharmacology. 259: 270-80. PMID 22230336 DOI: 10.1016/J.Taap.2011.12.017  0.728
2012 Prot JM, Leclerc E. The current status of alternatives to animal testing and predictive toxicology methods using liver microfluidic biochips. Annals of Biomedical Engineering. 40: 1228-43. PMID 22160577 DOI: 10.1007/S10439-011-0480-5  0.643
2011 Prot JM, Briffaut AS, Letourneur F, Chafey P, Merlier F, Grandvalet Y, Legallais C, Leclerc E. Integrated proteomic and transcriptomic investigation of the acetaminophen toxicity in liver microfluidic biochip. Plos One. 6: e21268. PMID 21857903 DOI: 10.1371/Journal.Pone.0021268  0.76
2011 Prot JM, Aninat C, Griscom L, Razan F, Brochot C, Guillouzo CG, Legallais C, Corlu A, Leclerc E. Improvement of HepG2/C3a cell functions in a microfluidic biochip. Biotechnology and Bioengineering. 108: 1704-15. PMID 21337338 DOI: 10.1002/Bit.23104  0.728
2011 Prot JM, Videau O, Brochot C, Legallais C, Bénech H, Leclerc E. A cocktail of metabolic probes demonstrates the relevance of primary human hepatocyte cultures in a microfluidic biochip for pharmaceutical drug screening. International Journal of Pharmaceutics. 408: 67-75. PMID 21295126 DOI: 10.1016/J.Ijpharm.2011.01.054  0.765
Low-probability matches (unlikely to be authored by this person)
2014 Esch MB, Smith AS, Prot JM, Oleaga C, Hickman JJ, Shuler ML. How multi-organ microdevices can help foster drug development. Advanced Drug Delivery Reviews. 69: 158-69. PMID 24412641 DOI: 10.1016/J.Addr.2013.12.003  0.3
2013 Sung JH, Esch MB, Prot JM, Long CJ, Smith A, Hickman JJ, Shuler ML. Microfabricated mammalian organ systems and their integration into models of whole animals and humans. Lab On a Chip. 13: 1201-12. PMID 23388858 DOI: 10.1039/C3Lc41017J  0.216
2019 Coln EA, Colon A, Long CJ, Sriram NN, Esch M, Prot J, Elbrecht DH, Wang Y, Jackson M, Shuler ML, Hickman JJ. Piezoelectric bioMEMS cantilever for measurement of muscle contraction and for actuation of mechanosensitive cells Mrs Communications. 9: 1186-1192. DOI: 10.1557/Mrc.2019.129  0.203
2019 Coln EA, Colon A, Long CJ, Sriram NN, Esch M, Prot JM, Elbrecht DH, Wang Y, Jackson M, Shuler ML, Hickman JJ. Piezoelectric BioMEMS Cantilever for Measurement of Muscle Contraction and for Actuation of Mechanosensitive Cells. Mrs Communications. 9: 1186-1192. PMID 33777497 DOI: 10.1557/mrc.2019.129  0.108
Hide low-probability matches.